iPrime Viscodelivery System
Jan 2022
126d
Glaukos has submitted 1 FDA 510(k) premarket notifications since 2022, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Pump, Infusion, Ophthalmic . Use the specialty filter in the sidebar to narrow results.